Neutralization is observed for the first few concentrations for both antibodies. Antibody A reaches a 50% neutralizing titer (NT50) at a lower concentration and demonstrates more neutralizing potency against IFV-B/Brisbane/60/2008 than Antibody B. The recorded NT50 of the internal control fell within the expected range.